483
Hospi CorporationFDA 483 - Hospi Corporation - March 14, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Hospi Corporation in San Mateo, CA, revealed significant deficiencies in the firm's quality system. The company failed to adequately establish and implement procedures for complaint handling, resulting in insufficient investigations into product defects for Macy catheters. Additionally, Hospi Corporation did not submit a required Medical Device Report (MDR) within 30 days for a serious adverse event involving a patient infection.
- Person
Open in Dashboard
ID · d9d2b222-35fc-42d4-9cce-498df5863f96